Full Press Release Details
TARRYTOWN, N.Y. , Aug. 10, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Christine Sacco , CFO and COO, and Phil Terpolilli , VP, Investor Relations, Treasury , & Business Development will participate in a fireside chat at the Canaccord Genuity 46 th Annual Growth Conference on Wednesday August 12, 2026 at 10:00 a.m. ET . A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:
For those unable to participate during the live webcast, a replay option will be available on the Company’s website following the event.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Breathe Right ® nasal strips, Monistat ® and Summer’s Eve ® women's health products, BC ® and Goody's ® pain relievers, Clear Eyes ® and TheraTears ® eye care products, DenTek ® specialty oral care products, Dramamine ® motion sickness treatments, Fleet ® enemas and glycerin suppositories, Chloraseptic ® and Luden's ® sore throat treatments and drops, Compound W ® wart treatments, Little Remedies ® pediatric over-the-counter products, Boudreaux’s Butt Paste ® diaper rash ointments, Nix ® lice treatment, Debrox ® earwax remover, Gaviscon ® antacid in Canada, as well as Hydralyte ® rehydration products and the Dermal Therapy ® line of therapeutic skin care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com .